{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:32:36Z","timestamp":1793831556521,"version":"4.6.1"},"reference-count":146,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Laser treatment has been a mainstay for management of central serous chorioretinopathy for a few decades. Different types of lasers have been used and non-damaging retinal laser is the most recent option. The aim of this review is to provide an update on this form of treatment, based on the research published during last 5 years, in comparison with earlier studies published. A MEDLINE database search was performed with a combination of the following terms: central serous chorioretinopathy and laser photocoagulation or subthreshold laser or subthreshold micropulse laser or nanosecond laser or microsecond laser or end-point management or photodynamic therapy. Results were analyzed separately for each modality of laser treatment. Reports published in recent years confirm findings of previous research and do not distinguish treatments of this clinical entity. Among all analyzed laser options, photodynamic therapy provides the fastest and most prominent morphological\n          improvements, including subretinal fluid resorption and reduction of choroidal thickness. This modality is also associated with fewer recurrences than with other treatments. Subthreshold micropulse laser allows the physician to maintain and, in selected cases, improve the patient\u02bcs vision. Conventional photocoagulation is still effective, especially with the introduction of navigated laser systems. Despite the availability of variable laser treatment options, long-term functional improvements in chronic cases are minor for each modality. Long-lasting central serous chorioretinopathy cases with significantly altered retinal morphology do not usually present with functional improvement, despite satisfactory morphological outcomes. Early initiation of treatment has the potential to prevent visual loss and to improve the patient\u02bcs quality of life.<\/jats:p>","DOI":"10.1055\/a-2338-3235","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T22:56:25Z","timestamp":1721861785000},"page":"1207-1223","source":"Crossref","is-referenced-by-count":4,"title":["Laser Treatment of Central Serous Chorioretinopathy \u2013 An Update"],"prefix":"10.1055","volume":"241","author":[{"given":"Maciej","family":"Gawecki","sequence":"additional","affiliation":[{"name":"Ophthalmology, Dobry Wzrok Ophthalmological Clinic, Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Pytrus","sequence":"additional","affiliation":[{"name":"Ophthalmology, University Hospital Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Swiech","sequence":"additional","affiliation":[{"name":"Chair of Ophthalmology, Department of Vitreoretinal Surgery, Medical University of Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Mackiewicz","sequence":"additional","affiliation":[{"name":"Chair of Ophthalmology, Department of Vitreoretinal Surgery, Medical University of Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubomyr","family":"Lytvynchuk","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Eye Clinic, Justus Liebig University, University Hospital Giessen and Marburg, Campus Giessen, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Central Serous Chorioretinopathy International Group. Multimodal Imaging-Based Central Serous Chorioretinopathy Classification","volume":"4","author":"J Chhablani","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02150023","article-title":"Pathogenesis of central serous retinopathy: a new working hypothesis","volume":"224","author":"M Spitznas","year":"1986","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF02169203","article-title":"New hypotheses on the pathogenesis and treatment of serous retinal detachment","volume":"226","author":"M F Marmor","year":"1988","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.10.13.6","article-title":"Acute Central Serous Chorioretinopathy Subtypes as Assessed by Multimodal Imaging","volume":"10","author":"A Arrigo","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"ref5","volume-title":"Discussion of Central Serous Retinopathy. Modern Problems in Ophthalmology, Vol. 12, 361","author":"J DM Gass","year":"1974"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.63.10.674","article-title":"Argon laser photocoagulation in the treatment of central serous retinopathy","volume":"63","author":"P Leaver","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy","volume":"95","author":"D M Robertson","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/a-2227-4037","article-title":"Effective Focal Laser Photocoagulation for Persistent Central Serous Chorioretinopathy: A Forgotten Technique","author":"P Kiraly","year":"2024","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10384-023-00976-x","article-title":"Quadrant laser photocoagulation trial to ameliorate choroidal congestion in central serous chorioretinopathy","volume":"67","author":"H Matsumoto","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1159\/000527439","article-title":"Focal Laser Photocoagulation for Central Serous Chorioretinopathy in Under-Represented Populations: A Retrospective Case Series","volume":"13","author":"K Sangal","year":"2022","journal-title":"Case Rep Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12886-022-02732-0","article-title":"Morphometric analyses in patients treated with subthreshold laser photocoagulation for central serous chorioretinopathy","volume":"22","author":"C Enders","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7792291","DOI":"10.1155\/2022\/7792291","article-title":"Efficacy of Navigated Laser Photocoagulation for Chronic Central Serous Chorioretinopathy: A Retrospective Observational Study","volume":"2022","author":"F Zhou","year":"2022","journal-title":"Dis Markers"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000519234","article-title":"Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd\u200a:\u200aYAG Continuous-Wave Laser","volume":"245","author":"C Enders","year":"2022","journal-title":"Ophthalmologica"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/joco.joco_257_21","article-title":"Dark-Field Scanning Laser Ophthalmoscopy for Prediction of Central Serous Chorioretinopathy Responsiveness to Laser Therapy","volume":"33","author":"A N Kulikov","year":"2022","journal-title":"J Curr Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.3928\/23258160-20190401-16","article-title":"Clinical Application of Fluorescein Angiography-Free Navigated Focal Laser Photocoagulation in Central Serous Chorioretinopathy","volume":"50","author":"D S Maltsev","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0161-6420(97)30262-0","article-title":"Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up","volume":"104","author":"E Burumcek","year":"1997","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3928\/15428877-20090901-03","article-title":"Early laser photocoagulation treatment as an option in central serous chorioretinopathy","volume":"40","author":"V Sturm","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0161-6420(97)30262-0","article-title":"Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up","volume":"104","author":"E Burumcek","year":"1997","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2415-4-15","article-title":"Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]","volume":"4","author":"L Verma","year":"2004","journal-title":"BMC Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/jcm8020242","article-title":"Micropulse Laser Treatment of Retinal Diseases","volume":"8","author":"M Gaw\u0119cki","year":"2019","journal-title":"J Clin Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","article-title":"A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders","volume":"34","author":"P Scholz","year":"2017","journal-title":"Adv Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.5.23","article-title":"Comparison of Subthreshold 577 and 810\u2009nm Micropulse Laser Effects on Heat-Shock Protein Activation Kinetics: Implications for Treatment Efficacy and Safety","volume":"9","author":"D B Chang","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/IAE.0b013e3182206f6c","article-title":"Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema","volume":"32","author":"J K Luttrull","year":"2012","journal-title":"Retina"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.18240\/ijo.2023.06.14","article-title":"Efficacy and safety of subthreshold micropulse laser in the treatment of acute central serous chorioretinopathy","volume":"16","author":"J J Guo","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"ref25","first-page":"1194","article-title":"Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy","volume":"13","author":"P Kiraly","year":"2023","journal-title":"Life (Basel)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"103552","DOI":"10.1016\/j.pdpdt.2023.103552","article-title":"Prognosis evaluation with optical coherence tomography in chronic central serous chorioretinopathy","volume":"42","author":"F B Kaplan","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1177\/11206721211064021","article-title":"Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response","volume":"32","author":"F Amoroso","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12886-022-02472-1","article-title":"OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy","volume":"22","author":"F Zheng","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s10103-022-03574-4","article-title":"Morphological parameters predicting subthreshold micropulse laser effectiveness in central serous chorioretinopathy","volume":"37","author":"P Kiraly","year":"2022","journal-title":"Lasers Med Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3390\/jcm10112418","article-title":"Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study","volume":"10","author":"M Prasuhn","year":"2021","journal-title":"J Clin Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10103-020-03225-6","article-title":"Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy","volume":"36","author":"M G Alt\u0131nel","year":"2021","journal-title":"Lasers Med Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.18240\/ijo.2020.09.11","article-title":"Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy","volume":"13","author":"M U I\u015f\u0131k","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08820538.2020.1809682","article-title":"Subthreshold Micro-Pulse Yellow Laser and Eplerenone Drug Therapy in Chronic Central Serous Chorio-Retinopathy Patients: A Comparative Study","volume":"35","author":"T P Vignesh","year":"2020","journal-title":"Semin Ophthalmol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-018-0309-7","article-title":"Short-duration multiple-session subthreshold micropulse yellow laser (577\u2009nm) for chronic central serous chorioretinopathy: results at 3 years","volume":"33","author":"Y J Kim","year":"2019","journal-title":"Eye (Lond)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cxo.12818","article-title":"Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy","volume":"102","author":"S Arora","year":"2019","journal-title":"Clin Exp Optom"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/jcm8091398","article-title":"Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset","volume":"8","author":"M Gaw\u0119cki","year":"2019","journal-title":"J Clin Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10103-019-02721-8","article-title":"A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy","volume":"34","author":"L Zhou","year":"2019","journal-title":"Lasers Med Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00417-017-3783-x","article-title":"Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser","volume":"255","author":"M Gaw\u0119cki","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up","volume":"32","author":"A Arsan","year":"2018","journal-title":"Eye (Lond)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"103221","DOI":"10.1016\/j.pdpdt.2022.103221","article-title":"Electrophysiological and anatomical outcomes of subthreshold micropulse laser therapy in chronic central serous chorioretinopathy","volume":"41","author":"B Kayhan","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s00417-021-05256-3","article-title":"Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy","volume":"259","author":"B Schworm","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.2147\/OPTH.S284005","article-title":"Modified Low Power Mode Laser for the Treatment of Central Serous Chorioretinopathy","volume":"14","author":"M Miura","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"115002","DOI":"10.1117\/1.JBO.23.11.115002","article-title":"Selective retina therapy: toward an optically controlled automatic dosing","volume":"23","author":"E Seifert","year":"2018","journal-title":"J Biomed Opt"},{"issue":"302","key":"ref44","first-page":"51","article-title":"Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results","author":"R Brinkmann","year":"2006","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/jcm11020323","article-title":"Factors Predicting Response to Selective Retina Therapy in Patients with Chronic Central Serous Chorioretinopathy","volume":"11","author":"M Kim","year":"2022","journal-title":"J Clin Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1038\/s41598-021-88372-8","article-title":"Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy","volume":"11","author":"A Kyo","year":"2021","journal-title":"Sci Rep"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e001517","DOI":"10.1136\/bmjophth-2023-001517","article-title":"Selective retina therapy with real-time feedback-controlled technology in central serous chorioretinopathy: a 24-month follow-up real-world prospective study","volume":"9","author":"C K Yoon","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3341\/kjo.2020.0112","article-title":"Evaluation of the Safety and Efficacy of Selective Retina Therapy Laser Treatment in Patients with Central Serous Chorioretinopathy","volume":"35","author":"J Oh","year":"2021","journal-title":"Korean J Ophthalmol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00417-020-04999-9","article-title":"Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results","volume":"259","author":"M B\u00fcttner","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000520187","article-title":"The Effect of Selective Retina Therapy for Bevacizumab-Resistant Chronic Central Serous Chorioretinopathy","volume":"245","author":"S H Jeon","year":"2022","journal-title":"Ophthalmologica"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3390\/jcm10194295","article-title":"The Effect of Selective Retina Therapy with Automatic Real-Time Feedback-Controlled Dosimetry for Chronic Central Serous Chorioretinopathy: A Randomized, Open-Label, Controlled Clinical Trial","volume":"10","author":"J Y Lee","year":"2021","journal-title":"J Clin Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40942-020-00214-3","article-title":"Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium","volume":"6","author":"H Kaymak","year":"2020","journal-title":"Int J Retina Vitreous"},{"key":"ref53","first-page":"60","article-title":"[Nanosecond Laser Treatment in Chorioretinopathia Centralis Serosa without RPE Defects: A Retrospective Case Series]","volume":"238","author":"S Funk","year":"2021","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/ph13110349","article-title":"Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy","volume":"13","author":"P Iacono","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref55","first-page":"4081874","article-title":"Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy","volume":"2018","author":"M P Ruiz-Del-Tiempo","year":"2018","journal-title":"J Ophthalmol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study","volume":"33","author":"R M Silva","year":"2013","journal-title":"Retina"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00417-011-1900-9","article-title":"Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy","volume":"250","author":"S Copete","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","article-title":"A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy","volume":"170","author":"F H Lai","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bjophthalmol-2014-305353","article-title":"Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy","volume":"99","author":"C C Tseng","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3390\/ijms18112468","article-title":"Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy","volume":"18","author":"M Nassisi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref61","first-page":"4542","article-title":"Effect of Low-dose Photodynamic Therapy at the Choriocapillaris Level on Optical Coherence Tomography Angiography in Patients with Chronic Central Serous Chorioretinopathy","volume":"60","author":"E Reifeltshammer","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s10792-023-02822-y","article-title":"Early versus delayed photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"G Katz","year":"2023","journal-title":"Int Ophthalmol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00417-023-06147-5","article-title":"Optical coherence tomography angiography-guided vs. indocyanine green angiography-guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results","volume":"261","author":"S Li","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref64","first-page":"1356","article-title":"Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy","volume":"43","author":"L Pauleikhoff","year":"2023","journal-title":"Retina"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e0284979","DOI":"10.1371\/journal.pone.0284979","article-title":"Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization","volume":"18","author":"A Kamimura","year":"2023","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"103316","DOI":"10.1016\/j.pdpdt.2023.103316","article-title":"Fuji sign: Prevalence and predictive power to photodynamic therapy in chronic central serous chorioretinopathy","volume":"42","author":"P P\u00e9rez-Garc\u00eda","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/IAE.0000000000003686","article-title":"Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"H Feenstra","year":"2023","journal-title":"Retina"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41433-022-02370-2","article-title":"Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy","volume":"37","author":"S Khandhadia","year":"2023","journal-title":"Eye (Lond)"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/IAE.0000000000003604","article-title":"Effects of half-dose photodynamic therapy on chronic central serous chorioretinopathy with or without macular neovascularization assessed using optical coherence tomography angiography","volume":"42","author":"K Nakamura","year":"2022","journal-title":"Retina"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"100152","DOI":"10.1016\/j.xops.2022.100152","article-title":"Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis","volume":"2","author":"N Aisu","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00417-022-05836-x","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No.\u20093","volume":"261","author":"H Feenstra","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"103107","DOI":"10.1016\/j.pdpdt.2022.103107","article-title":"Prediction of the response to photodynamic therapy in patients with chronic central serous chorioretinopathy based on optical coherence tomography using deep learning","volume":"40","author":"J I Fern\u00e1ndez-Vigo","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"102984","DOI":"10.1016\/j.pdpdt.2022.102984","article-title":"Factors for recurrence in acute central serous chorioretinopathy patients underwent one-third dose verteporfin photodynamic therapy","volume":"39","author":"X Zhang","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00417-021-05531-3","article-title":"Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-na\u00efve central serous chorioretinopathy","volume":"260","author":"M Li","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial","volume":"233","author":"T van Rijssen","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ph14010053","article-title":"Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy","volume":"14","author":"Y Wakatsuki","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41433-020-0858-4","article-title":"Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin","volume":"35","author":"Z Liang","year":"2021","journal-title":"Eye (Lond)"},{"key":"ref78","first-page":"298","article-title":"Assessment of the efficacy of photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"75","author":"K Manethov\u00e1","year":"2020","journal-title":"Cesk Slov Oftalmol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3928\/23258160-20191119-03","article-title":"Long-Term Efficacy and Safety of Photodynamic Therapy in Patients with Chronic Central Serous Chorioretinopathy","volume":"50","author":"Y J Park","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/08820538.2021.1931357","article-title":"Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study","volume":"37","author":"C Pinto","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"102704","DOI":"10.1016\/j.pdpdt.2021.102704","article-title":"Longitudinal multimodal functional macular analysis after half-dose photodynamic therapy for central serous chorioretinopathy","volume":"37","author":"S Penas","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2023.05.022","article-title":"Characteristics Related to Visual Acuity Loss After Successful Photodynamic Therapy for Eyes with Central Serous Chorioretinopathy","volume":"256","author":"R Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2023.04.016","article-title":"A Photodynamic Therapy Index for Central Serous Chorioretinopathy to Predict Visual Prognosis Using Pretreatment Factors","volume":"253","author":"R Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41433-020-1018-6","article-title":"Relationship between photoreceptor layer changes before half-dose photodynamic therapy and functional and anatomic outcomes in central serous chorioretinopathy","volume":"35","author":"J Yu","year":"2021","journal-title":"Eye (Lond)"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e0240557","DOI":"10.1371\/journal.pone.0240557","article-title":"Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity","volume":"15","author":"M Hayashida","year":"2020","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41433-021-01762-0","article-title":"Threshold thickness of foveal outer nuclear layer associated with outcomes of photodynamic therapy in central serous chorioretinopathy","volume":"36","author":"J Yu","year":"2022","journal-title":"Eye (Lond)"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10103-022-03676-z","article-title":"Morphological integrity of the outer retinal layers and visual prognosis in chronic central serous chorioretinopathy after half-dose photodynamic therapy: a qualitative SD-OCT analysis","volume":"38","author":"H Gobeka","year":"2022","journal-title":"Lasers Med Sci"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/OPTH.S242926","article-title":"Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy","volume":"14","author":"D Mohabati","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/1120672120915168","article-title":"A randomized clinical trial comparing prompt photodynamic therapy with 3 months observation in patients with acute central serous chorioretinopathy with central macular leakage","volume":"31","author":"T Missotten","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"102235","DOI":"10.1016\/j.pdpdt.2021.102235","article-title":"Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy","volume":"34","author":"S Torres-Costa","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12886-019-1089-y","article-title":"The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"19","author":"J Yu","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1177\/11206721211046497","article-title":"One-year outcome of cystoid macular degeneration in central serous chorioretinopathy","volume":"32","author":"N Kumar Sahoo","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s10384-021-00815-x","article-title":"Characteristics and treatment responses of cystoid retina associated with central serous chorioretinopathy","volume":"65","author":"H Fukuyama","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1038\/s41598-023-37802-w","article-title":"Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy","volume":"13","author":"N Nishigori","year":"2023","journal-title":"Sci Rep"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2020.04.022","article-title":"Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study","volume":"217","author":"C Iovino","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"102347","DOI":"10.1016\/j.pdpdt.2021.102347","article-title":"Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"35","author":"E Esen","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"18689","DOI":"10.1038\/s41598-022-22984-6","article-title":"DeepPDT-Net: predicting the outcome of photodynamic therapy for chronic central serous chorioretinopathy using two-stage multimodal transfer learning","volume":"12","author":"T K Yoo","year":"2022","journal-title":"Sci Rep"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"e0284899","DOI":"10.1371\/journal.pone.0284899","article-title":"Factors related to changes in visual symptoms after successful photodynamic therapy in central serous chorioretinopathy","volume":"18","author":"G W Lee","year":"2023","journal-title":"PLoS One"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.10.13.6","article-title":"Acute Central Serous Chorioretinopathy Subtypes as Assessed by Multimodal Imaging","volume":"10","author":"A Arrigo","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211027060","article-title":"Early vessel occlusion and recanalization after photodynamic therapy in central serous chorioretinopathy by OCT angiography","author":"J I Fern\u00e1ndez-Vigo","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3390\/jcm9092734","article-title":"Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy","volume":"9","author":"C Alovisi","year":"2020","journal-title":"J Clin Med"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"102862","DOI":"10.1016\/j.pdpdt.2022.102862","article-title":"Early changes in choriocapillaris flow voids as an efficacy biomarker of photodynamic therapy in central serous chorioretinopathy","volume":"38","author":"J I Fern\u00e1ndez-Vigo","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref103","first-page":"699","article-title":"[Effect of low-dose PDT on perfusion of the choriocapillaris in cCSCR: An OCT-angiography-based study]","volume":"119","author":"E Reifeltshammer","year":"2022","journal-title":"Ophthalmologie"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12886-020-01674-9","article-title":"Assessment of choriocapillary blood flow changes in response to half-dose photodynamic therapy in chronic central serous chorioretinopathy using optical coherence tomography angiography","volume":"20","author":"J Liu","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12886-021-01980-w","article-title":"Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"21","author":"S Kumashiro","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1177\/11206721221131129","article-title":"OCT-A in chronic central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative study","author":"L Clemente","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"101742","DOI":"10.1016\/j.pdpdt.2020.101742","article-title":"Study of vessel density by optical coherence tomography angiography in patients with central serous chorioretinopathy after low-fluence photodynamic therapy","volume":"30","author":"G Cennamo","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00417-018-04226-6","article-title":"Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy","volume":"257","author":"S Demirel","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"4024603","DOI":"10.1155\/2022\/4024603","article-title":"Superficial Retinal Microvasculature and Choriocapillaris Alterations after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy","volume":"2022","author":"M Entezari","year":"2022","journal-title":"J Ophthalmol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"102477","DOI":"10.1016\/j.pdpdt.2021.102477","article-title":"Quantitative evaluation of damage to retinal capillaries caused by half-dose and half-time photodynamic therapy with optical coherent tomographic angiography","volume":"36","author":"F Xu","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/02713683.2020.1843684","article-title":"Quantitative Evaluation of Retinal Vessel Density in Central Serous Chorioretinopathy after Half-dose Photodynamic Therapy","volume":"46","author":"F Xu","year":"2021","journal-title":"Curr Eye Res"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1038\/s41598-021-92693-z","article-title":"3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization","volume":"11","author":"Y C Hu","year":"2021","journal-title":"Sci Rep"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1097\/IAE.0000000000003615","article-title":"Multimodal imaging features and treatment responses of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"42","author":"A Jeong","year":"2022","journal-title":"Retina"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41433-020-01345-5","article-title":"OCTA evaluation of treatment-na\u00efve flat irregular PED (FIPED)-associated CNV in chronic central serous chorioretinopathy before and after half-dose PDT","volume":"35","author":"J Guo","year":"2021","journal-title":"Eye (Lond)"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"102081","DOI":"10.1016\/j.pdpdt.2020.102081","article-title":"Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy","volume":"33","author":"M G Altinel","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00417-019-04426-8","article-title":"Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence","volume":"257","author":"W Park","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-020-01796-0","article-title":"One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy","volume":"21","author":"J Pichai","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjophthalmol-2020-316837","article-title":"Optimal fluence rate of photodynamic therapy for chronic central serous chorioretinopathy","volume":"105","author":"D G Park","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jfo.2021.04.011","article-title":"Comparison of Indocyanine Green Angiography and Fluorescein Angiography for Imaging of Central Serous Chorioretinopathy Patients as Candidates for Photodynamic Therapy","volume":"45","author":"F Kianersi","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s10792-020-01350-3","article-title":"Fluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy","volume":"40","author":"A Koytak","year":"2020","journal-title":"Int Ophthalmol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/s41598-023-28890-9","article-title":"Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy","volume":"13","author":"N Ebrahimiadib","year":"2023","journal-title":"Sci Rep"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"101955","DOI":"10.1016\/j.pdpdt.2020.101955","article-title":"Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy","volume":"31","author":"M Hayashida","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IAE.0000000000002795","article-title":"Optical coherence tomography angiography-guided photodynamic therapy for acute central serous chorioretinopathy","volume":"41","author":"J Hu","year":"2021","journal-title":"Retina"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/jop.2021.0120","article-title":"Photodynamic Therapy with Chlorin e6 Derivative for Chronic Central Serous Chorioretinopathy (Pilot Study)","volume":"38","author":"T Kustryn","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s40123-023-00739-4","article-title":"No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy","volume":"12","author":"A Servillo","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00417-017-3626-9","article-title":"Comparison of half-dose photodynamic therapy and 689\u2009nm laser treatment in eyes with chronic central serous chorioretinopathy","volume":"255","author":"A Russo","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"682264","DOI":"10.3389\/fmed.2021.682264","article-title":"Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial","volume":"8","author":"L Zhou","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41433-019-0692-8","article-title":"Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy","volume":"34","author":"Z Sun","year":"2020","journal-title":"Eye (Lond)"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"e0184112","DOI":"10.1371\/journal.pone.0184112","article-title":"Subthreshold 577\u2009nm micropulse laser treatment for central serous chorioretinopathy","volume":"12","author":"I Maruko","year":"2017","journal-title":"PLoS One"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12886-023-03274-9","article-title":"Half-dose photodynamic therapy versus 577\u2009nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy","volume":"24","author":"V Sitnilska","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.oret.2023.10.024","article-title":"Comparing Half-Dose Photodynamic Therapy with Subthreshold Micropulse Laser for the Treatment of Central Serous Chorioretinopathy","volume":"8","author":"M E Brelen","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"103908","DOI":"10.1016\/j.pdpdt.2023.103908","article-title":"A randomized non-inferiority trial of 577\u2009nm subthreshold micropulse laser versus half-dose photodynamic therapy for acute central serous chorioretinopathy","volume":"45","author":"L Zhou","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10384-023-00978-9","article-title":"Practical treatment options for persistent central serous chorioretinopathy and early visual and anatomical outcomes","volume":"67","author":"N Yamada-Okahara","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12886-022-02331-z","article-title":"Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy","volume":"22","author":"M Zeng","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"3627903","DOI":"10.1155\/2022\/3627903","article-title":"Subthreshold Micropulse Treatment Laser versus Half-Dose Photo Dynamic Therapy for the Chronic Central Serous Chorioretinopathy with Parafoveal or Subfoveal Leakage STML versus PDT for Treatment of Chronic CSC","volume":"2022","author":"Q Chen","year":"2022","journal-title":"J Ophthalmol"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/IAE.0000000000003363","article-title":"Efficacy of half-dose photodynamic therapy versus high-density subthreshold micropulse laser for treating pigment epithelial detachments in chronic central serous chorioretinopathy","volume":"42","author":"H Feenstra","year":"2022","journal-title":"Retina"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/IAE.0000000000003157","article-title":"Response of choroidal abnormalities to photodynamic therapy versus micropulse laser in chronic central serous chorioretinopathy: Place Trial Report No.\u20094","volume":"41","author":"T van Rijssen","year":"2021","journal-title":"Retina"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jfo.2020.08.027","article-title":"Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"44","author":"M Altinel","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/aos.14775","article-title":"Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser","volume":"99","author":"T van Rijssen","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjophthalmol-2020-316076","article-title":"Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy","volume":"105","author":"M Ho","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10384-019-00697-0","article-title":"Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy","volume":"64","author":"Y I Shin","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No.\u20093","volume":"205","author":"T van Rijssen","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/ph13110359","article-title":"Central Serous Chorioretinopathy: Treatment with Laser","volume":"13","author":"M Battaglia Parodi","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial","volume":"125","author":"E HC van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2020.04.007","article-title":"Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial","volume":"216","author":"T van Rijssen","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aopr.2024.01.004","article-title":"Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy","volume":"4","author":"M Gaw\u0119cki","year":"2024","journal-title":"Adv Ophthalmol Pract Res"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2338-3235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:08:50Z","timestamp":1731542930000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2338-3235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":146,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,13]]},"published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2338-3235","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}